DrGraham Wheeler
Honorary Senior Lecturer
School of Public Health - Faculty of Medicine
Orcid identifier0000-0002-3254-5991 (opens in a new tab)
- Honorary Senior LecturerSchool of Public Health - Faculty of Medicine
- 020 7594 8805 (Work)
- Stadium House, White City Campus, United Kingdom
RESEARCH
Previous Research Funding
“MICA Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) study”, CI Prof. Julian Marchesi (Imperial College London), MRC DPFS MR/X004996/1; 01/09/2022-28/02/2027. £1,728,017.
“Development of recombinant surfactant protein D therapy to prevent neonatal chronic lung disease”, CI Prof. Howard Clark (Southampton/UCL); MRC (MR/P026907/1; 2019-2021). £2,765,801.
“Investigating the therapeutic potential of biomarker targeted MSCTRAIL in malignant pleural mesothelioma”, CI Prof. Sam Janes (UCL); Innovate UK (105196; 2019-2021). £638,609.
“Phase I/II clinical trials evaluating AAV-mediated gene therapy for a severe paediatric metabolic liver disease: Ornithine Transcarbamylase deficiency”, CI Prof. Paul Gissen (UCL); MRC DPFS (MR/S019111/1; 2019-2023). £3,920,211.
“A Practical Adaptive and Novel Designs Toolkit (PANDA)”, CI Dr. Munya Dimairo (University of Sheffield); NIHR CTU Support Funding Opportunity (R/157221; 2019-2021). £98,886.
“Phase I study of transfer of effector memory T cells (Tem) following allogenic stem cell transplantation”, CI Prof. Ronjon Chakraverty (UCL); MRC DPFS (MR/R025436/1; 2018-2023). £1,040,481.
“Development of user-friendly web-based software for conducting Bayesian Phase I dose-escalation studies”, CI Dr Lisa Hampson (Lancaster University); MRC Hub for Trials Methodology Research (Project N78; 2016-2018). £35,477.
Previous Research Supervision
2020 - 2021: A. Uda, MPH, Imperial College London
2019 - 2020: D. Devassy, MSc Clinical Trials, UCL
2016 - 2017: A. Florou, MSc Clinical Trials, UCL
“MICA Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) study”, CI Prof. Julian Marchesi (Imperial College London), MRC DPFS MR/X004996/1; 01/09/2022-28/02/2027. £1,728,017.
“Development of recombinant surfactant protein D therapy to prevent neonatal chronic lung disease”, CI Prof. Howard Clark (Southampton/UCL); MRC (MR/P026907/1; 2019-2021). £2,765,801.
“Investigating the therapeutic potential of biomarker targeted MSCTRAIL in malignant pleural mesothelioma”, CI Prof. Sam Janes (UCL); Innovate UK (105196; 2019-2021). £638,609.
“Phase I/II clinical trials evaluating AAV-mediated gene therapy for a severe paediatric metabolic liver disease: Ornithine Transcarbamylase deficiency”, CI Prof. Paul Gissen (UCL); MRC DPFS (MR/S019111/1; 2019-2023). £3,920,211.
“A Practical Adaptive and Novel Designs Toolkit (PANDA)”, CI Dr. Munya Dimairo (University of Sheffield); NIHR CTU Support Funding Opportunity (R/157221; 2019-2021). £98,886.
“Phase I study of transfer of effector memory T cells (Tem) following allogenic stem cell transplantation”, CI Prof. Ronjon Chakraverty (UCL); MRC DPFS (MR/R025436/1; 2018-2023). £1,040,481.
“Development of user-friendly web-based software for conducting Bayesian Phase I dose-escalation studies”, CI Dr Lisa Hampson (Lancaster University); MRC Hub for Trials Methodology Research (Project N78; 2016-2018). £35,477.
Previous Research Supervision
2020 - 2021: A. Uda, MPH, Imperial College London
2019 - 2020: D. Devassy, MSc Clinical Trials, UCL
2016 - 2017: A. Florou, MSc Clinical Trials, UCL